Literature DB >> 3249763

Alzheimer's Disease Assessment Scale (ADAS).

R C Mohs, L Cohen.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3249763

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN： 0048-5764


× No keyword cloud information.
  29 in total

1.  Statin treatment and a disease-specific pattern of beta-amyloid peptides in Alzheimer's disease.

Authors:  Kina Höglund; Steinar Syversen; Piotr Lewczuk; Anders Wallin; Jens Wiltfang; Kaj Blennow
Journal:  Exp Brain Res       Date:  2005-06-04       Impact factor: 1.972

2.  Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study.

Authors:  B Ravina; M Putt; A Siderowf; J T Farrar; M Gillespie; A Crawley; H H Fernandez; M M Trieschmann; S Reichwein; T Simuni
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

Review 3.  Biomarkers in Alzheimer's disease: past, present and future.

Authors:  Katarzyna Gustaw-Rothenberg; Alan Lerner; David J Bonda; Hyoung-gon Lee; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

Review 4.  Subtle ethical dilemmas in geriatric management and clinical research.

Authors:  A J Rosin; Y van Dijk
Journal:  J Med Ethics       Date:  2005-06       Impact factor: 2.903

5.  CSF biomarkers and clinical progression of Parkinson disease.

Authors:  Sara Hall; Yulia Surova; Annika Öhrfelt; Henrik Zetterberg; Daniel Lindqvist; Oskar Hansson
Journal:  Neurology       Date:  2014-11-19       Impact factor: 9.910

6.  Correlation between cognitive brain function and electrical brain activity in dementia of Alzheimer type.

Authors:  T Dierks; L Frölich; R Ihl; K Maurer
Journal:  J Neural Transm Gen Sect       Date:  1995

7.  Actigraphy in agitated patients with dementia. Monitoring treatment outcomes.

Authors:  R Mahlberg; S Walther
Journal:  Z Gerontol Geriatr       Date:  2007-06       Impact factor: 1.281

8.  Domain-specific cognitive effects of tramiprosate in patients with mild to moderate Alzheimer's disease: ADAS-cog subscale results from the Alphase Study.

Authors:  D Saumier; A Duong; D Haine; D Garceau; J Sampalis
Journal:  J Nutr Health Aging       Date:  2009-11       Impact factor: 4.075

9.  Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial.

Authors:  S Akhondzadeh; M Noroozian; M Mohammadi; S Ohadinia; A H Jamshidi; M Khani
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

10.  Beware of white matter hyperintensities causing systematic errors in FreeSurfer gray matter segmentations!

Authors:  Mahsa Dadar; Olivier Potvin; Richard Camicioli; Simon Duchesne
Journal:  Hum Brain Mapp       Date:  2021-03-30       Impact factor: 5.038
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.